These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

257 related items for PubMed ID: 28403523

  • 1. Autologous cell suspension grafting in segmental vitiligo and piebaldism: a randomized controlled trial comparing full surface and fractional CO2 laser recipient-site preparations.
    Lommerts JE, Meesters AA, Komen L, Bekkenk MW, de Rie MA, Luiten RM, Wolkerstorfer A.
    Br J Dermatol; 2017 Nov; 177(5):1293-1298. PubMed ID: 28403523
    [Abstract] [Full Text] [Related]

  • 2.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 3.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 4. Simplified cellular grafting for treatment of vitiligo and piebaldism: the "6-well plate" technique.
    Goh BK, Chua XM, Chong KL, de Mil M, van Geel NA.
    Dermatol Surg; 2010 Feb; 36(2):203-7. PubMed ID: 20039922
    [Abstract] [Full Text] [Related]

  • 5. Long-term follow-up of leucoderma patients treated with transplants of autologous cultured melanocytes, ultrathin epidermal sheets and basal cell layer suspension.
    Olsson MJ, Juhlin L.
    Br J Dermatol; 2002 Nov; 147(5):893-904. PubMed ID: 12410698
    [Abstract] [Full Text] [Related]

  • 6. Long-term results of noncultured epidermal cellular grafting in vitiligo, halo naevi, piebaldism and naevus depigmentosus.
    van Geel N, Wallaeys E, Goh BK, De Mil M, Lambert J.
    Br J Dermatol; 2010 Dec; 163(6):1186-93. PubMed ID: 20804490
    [Abstract] [Full Text] [Related]

  • 7. Recipient-to-Donor Ratios in the Surgical Treatment of Vitiligo, Leukoderma, and Piebaldism: A Retrospective Review.
    Maghfour J, Bardhi R, Huggins R, Hamzavi IH, Mohammad TF.
    Dermatology; 2023 Dec; 239(5):828-831. PubMed ID: 37231873
    [Abstract] [Full Text] [Related]

  • 8. Epidermal grafting for vitiligo: a comparison of cultured and noncultured grafts.
    Lee DY, Lee JH.
    Clin Exp Dermatol; 2010 Apr; 35(3):325-6. PubMed ID: 20500202
    [No Abstract] [Full Text] [Related]

  • 9. Autologous cell suspension transplantation using a cell extraction device in segmental vitiligo and piebaldism patients: A randomized controlled pilot study.
    Komen L, Vrijman C, Tjin EP, Krebbers G, de Rie MA, Luiten RM, van der Veen JP, Wolkerstorfer A.
    J Am Acad Dermatol; 2015 Jul; 73(1):170-2. PubMed ID: 26089056
    [No Abstract] [Full Text] [Related]

  • 10. Combined treatment with fractional carbon dioxide laser, autologous platelet-rich plasma, and narrow band ultraviolet B for vitiligo in different body sites: A prospective, randomized comparative trial.
    Abdelghani R, Ahmed NA, Darwish HM.
    J Cosmet Dermatol; 2018 Jun; 17(3):365-372. PubMed ID: 28834191
    [Abstract] [Full Text] [Related]

  • 11. Donor to recipient ratios in the surgical treatment of vitiligo and piebaldism: a systematic review.
    Narayan VS, van den Bol LLC, van Geel N, Bekkenk MW, Luiten RM, Wolkerstorfer A.
    J Eur Acad Dermatol Venereol; 2021 May; 35(5):1077-1086. PubMed ID: 33428279
    [Abstract] [Full Text] [Related]

  • 12. Permanent repigmentation of piebaldism by erbium:YAG laser and autologous cultured epidermis.
    Guerra L, Primavera G, Raskovic D, Pellegrini G, Golisano O, Bondanza S, Kuhn S, Piazza P, Luci A, Atzori F, De Luca M.
    Br J Dermatol; 2004 Apr; 150(4):715-21. PubMed ID: 15099368
    [Abstract] [Full Text] [Related]

  • 13. Epidermal sheet grafts for repigmentation of vitiligo and piebaldism, with a review of surgical techniques.
    Olsson MJ, Juhlin L.
    Acta Derm Venereol; 1997 Nov; 77(6):463-6. PubMed ID: 9394984
    [Abstract] [Full Text] [Related]

  • 14. Comparison between autologous noncultured epidermal cell suspension and suction blister epidermal grafting in stable vitiligo: a randomized study.
    Budania A, Parsad D, Kanwar AJ, Dogra S.
    Br J Dermatol; 2012 Dec; 167(6):1295-301. PubMed ID: 22897617
    [Abstract] [Full Text] [Related]

  • 15. Comparison of suction blister and carbon dioxide laser for recipient site preparation in epidermal grafting of segmental vitiligo.
    Lee DY, Choi SC, Lee JH.
    Clin Exp Dermatol; 2010 Apr; 35(3):328-9. PubMed ID: 19758388
    [No Abstract] [Full Text] [Related]

  • 16. Twelve-month and sixty-month outcomes of noncultured cellular grafting for vitiligo.
    Gan EY, Kong YL, Tan WD, Thng ST, Goh BK.
    J Am Acad Dermatol; 2016 Sep; 75(3):564-571. PubMed ID: 27180264
    [Abstract] [Full Text] [Related]

  • 17. Impact of graft cell density and viability on repigmentation upon noncultured autologous cell suspension transplantation in vitiligo and piebaldism.
    Uitentuis SE, Willemsen KJ, Lommerts JE, Komen L, Tjin EPM, Bekkenk MW, Wolkerstorfer A, Luiten RM.
    Clin Exp Dermatol; 2020 Oct; 45(7):907-908. PubMed ID: 32311146
    [No Abstract] [Full Text] [Related]

  • 18. Surgical combination therapy for vitiligo and piebaldism.
    Falabella R, Barona M, Escobar C, Borrero I, Arrunategui A.
    Dermatol Surg; 1995 Oct; 21(10):852-7. PubMed ID: 7551740
    [Abstract] [Full Text] [Related]

  • 19. Double-blind placebo-controlled study of autologous transplanted epidermal cell suspensions for repigmenting vitiligo.
    van Geel N, Ongenae K, De Mil M, Haeghen YV, Vervaet C, Naeyaert JM.
    Arch Dermatol; 2004 Oct; 140(10):1203-8. PubMed ID: 15492182
    [Abstract] [Full Text] [Related]

  • 20. Efficacy of Transplantation of Combination of Noncultured Dermal and Epidermal Cell Suspension vs Epidermal Cell Suspension Alone in Vitiligo: A Randomized Clinical Trial.
    Thakur V, Kumar S, Kumaran MS, Kaushik H, Srivastava N, Parsad D.
    JAMA Dermatol; 2019 Feb 01; 155(2):204-210. PubMed ID: 30601885
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 13.